In the News |
May 21, 2026
How To Shine As Biotech Comes Back From the Brink

Mohit (Mo) Trikha is the CEO of Kivu Bioscience. He brings over 25 years of drug development expertise in
oncology. He has been instrumental in advancing more than 40 programs from target identification to clinical trials in oncology.